Loading
Life sciences · Journal article
Pharmacognosy Magazine · September 4, 2026
Raises a question worth testing. It does not answer one.
This is an in vitro mechanistic study of wogonoside (WOG), a flavonoid from Scutellaria baicalensis, on oral cancer KB cell lines. The authors report dose-dependent decreases in cell survival and mitochondrial membrane potential, increased apoptosis, and elevated reactive oxygen species, but provide no quantitative effect sizes, confidence intervals, p-values, or comparisons to standard chemotherapeutic agents.
In vitro cell line study. KB oral cancer cell line. Intervention: Wogonoside (WOG) at varying doses.
Dose-based WOG treatment decreased cell survival and mitochondrial membrane potential in KB oral cancer cells WOG-treated cell lines showed greater proportion of apoptotic cells than healthy cells Elevated ROS levels induced by WOG treatment were associated with apoptosis
Cell line only; no animal or human efficacy or safety data provided
This preclinical finding does not support clinical use. In vitro data on surrogate endpoints require validation in animal models and clinical trials before any inference about therapeutic utility in patients with oral cancer.
In vitro mechanistic study of a plant-derived compound on cancer cells without clinical outcome data, control group specification, or quantitative effect sizes.
As stated by the source record.
This preclinical finding does not support clinical use. In vitro data on surrogate endpoints require validation in animal models and clinical trials before any inference about therapeutic utility in patients with oral cancer.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Background Cancer is currently regarded as one of the leading causes of high rates of death and morbidity worldwide. One of the main causes of mortality globally is still oral cancer, which is more common in underdeveloped nations where tobacco and betel nut chewing are common. Treatment plans frequently include surgery, targeted therapy, immunotherapy, hormone therapy, radiotherapy and chemotherapy. Scutellaria baicalensis Georgi, a popular anti-inflammatory plant in China, yields wogonoside (WOG), a bioactive flavonoid. Purpose Numerous recent studies have demonstrated WOG’s anti-cancer effectiveness in a variety of cancer models, such as those of osteosarcoma, leukaemia and breast cancer. Materials and Methods WOG’s impact on oral cancer (KB) cell survival, lactate dehydrogenase activity as an indicator of cellular damage, reactive oxygen species (ROS) formation assessed using dichlorodihydrofluorescein diacetate staining and mitochondrial membrane potential (MMP) assessed using Rh-123 staining is being examined in this study. Results Cell survival and the amount of MMP were decreased by dose-based WOG treatment. In the cell lines treated with WOG, the proportion of apoptotic cells was greater than that of healthy cells. Oxidative stress brought on by elevated ROS levels causes apoptosis. Conclusion This discovery implies that WOG has anti-tumour action and can be employed as a strong chemotherapeutic drug.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.